| It is currently Sat May 25, 2013 7:06 pm |
|
All times are UTC - 8 hours [ DST ] |
|
Page 1 of 1 |
[ 1 post ] |
|
| Author | Message | |||||
|---|---|---|---|---|---|---|
| squiffy2 |
|
|||||
Joined: Wed Oct 14, 2009 3:00 pm Posts: 1689 |
|
|||||
| Top | |
|||||
|
Page 1 of 1 |
[ 1 post ] |
|
All times are UTC - 8 hours [ DST ] |
| Topics | Author | Replies | Views | Last post | |
|---|---|---|---|---|---|
| New Data Alter Natalizumab Safety Considerations in MS | 1 | 896 | Mon May 16, 2011 7:41 pm | ||
| Tysabri Efficacy | 3 | 1827 | Wed Jan 11, 2006 10:02 pm | ||
| Tsyabri Efficacy Rate | 7 | 691 | Fri Dec 28, 2012 8:01 am | ||
| Natalizumab benefits | 2 | 1949 | Tue Sep 12, 2006 6:40 pm | ||
| PML associated with natalizumab in paediatric MS | 1 | 652 | Mon Oct 31, 2011 7:08 am | ||
Who is online |
Users browsing this forum: No registered users |
| You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum |